Seth A. Wander

The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer

Seth A. Wander, Ofir Cohen, Xueqian Gong et al. · Cancer Discovery · 2020 · 433 citations · Full text

Medicine, Cancer Biology, Oncology +17

Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies

Utthara Nayar, Ofir Cohen, Christian Kapstad et al. · Nature Genetics · 2018 · 239 citations

Medicine, Cancer Biology, Oncology +14

Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b–Mediated Malignant Progression

Manuel Picon‐Ruiz, Chendong Pan, Katherine Drews‐Elger et al. · Cancer Research · 2016 · 186 citations

Medicine, Cell Biology, Oncology +17

Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer

Pingping Mao, Ofir Cohen, Kailey J. Kowalski et al. · Clinical Cancer Research · 2020 · 185 citations

Medicine, Molecular Genetics, Oncology +17

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

Adrienne G. Waks, Ofir Cohen, Bose Kochupurakkal et al. · Annals of Oncology · 2020 · 156 citations · Full text

Medicine, Cancer Biology, Oncology +17